Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price was down 6.8% during trading on Thursday. The stock traded as low as $34.91 and last traded at $35.0460. 543,225 shares were traded during trading, a decline of 81% from the average session volume of 2,821,889 shares. The stock had previously closed at $37.59.
Acadia Healthcare News Summary
Investors following ACHC have been watching these news items:
- Positive Sentiment: Zacks also lifted estimates for several individual quarters, including Q4 2026 to $0.35 EPS from $0.27 and Q3 2028 to $0.65 from $0.62, adding to the broadly improved earnings outlook.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Leerink Partners lifted their price target on Acadia Healthcare from $30.00 to $33.00 and gave the company a "market perform" rating in a research report on Wednesday, September 23rd. Barclays raised their target price on Acadia Healthcare from $32.00 to $35.00 and gave the company an "equal weight" rating in a research note on Thursday, November 5th. Wall Street Zen raised Acadia Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, November 7th. Raymond James Financial began coverage on shares of Acadia Healthcare in a research report on Wednesday, November 4th. They issued a "moderate buy" rating on the stock. Finally, Zacks Research raised shares of Acadia Healthcare from a "hold" rating to a "strong-buy" rating in a report on Monday, November 9th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have given a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $32.54.
Check Out Our Latest Research Report on ACHC
Acadia Healthcare Price Performance
The stock has a 50-day moving average of $31.04 and a two-hundred day moving average of $27.10. The firm has a market cap of $3.26 billion, a price-to-earnings ratio of -2.80, a price-to-earnings-growth ratio of 4.76 and a beta of 0.64. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.15.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.46 by $0.14. The business had revenue of $895.31 million during the quarter, compared to analysts' expectations of $877.76 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.07%. Acadia Healthcare's revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.72 earnings per share. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 1.74 EPS for the current year.
Institutional Investors Weigh In On Acadia Healthcare
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Allworth Financial LP acquired a new position in shares of Acadia Healthcare in the second quarter worth $45,000. Global Retirement Partners LLC acquired a new stake in Acadia Healthcare during the second quarter valued at $68,000. Integrated Wealth Concepts LLC purchased a new position in Acadia Healthcare in the second quarter valued at about $79,000. Quantbot Technologies LP purchased a new position in Acadia Healthcare in the second quarter valued at about $88,000. Finally, Hantz Financial Services Inc. increased its position in Acadia Healthcare by 34.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 3,006 shares of the company's stock worth $83,000 after purchasing an additional 776 shares during the last quarter.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.